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Mapping gene regulatory circuitry of Pax6 during
neurogenesis
Sudhir Thakurela1,5, Neha Tiwari2,5, Sandra Schick1, Angela Garding1, Robert Ivanek3, Benedikt Berninger2,4,
Vijay K Tiwari1
1Institute of Molecular Biology (IMB), Ackermannweg 4, Mainz, Germany; 2Institute of Physiological Chemistry, University
Medical Center of the Johannes Gutenberg University Mainz, Hanns-Dieter-Hüsch-Weg 19, Mainz, Germany; 3Department of
Biomedicine, University of Basel, Basel, Switzerland; 4Focus Program Translational Neuroscience, Johannes Gutenberg Uni-
versity Mainz, Langenbeckstr. 1, Mainz, Germany
Pax6 is a highly conserved transcription factor among vertebrates and is important in various aspects of the
central nervous system development. However, the gene regulatory circuitry of Pax6 underlying these functions
remains elusive. We ﬁnd that Pax6 targets a large number of promoters in neural progenitors cells. Intriguingly, many of
these sites are also bound by another progenitor factor, Sox2, which cooperates with Pax6 in gene regulation. A combi-
natorial analysis of Pax6-binding data set with transcriptome changes in Pax6-deﬁcient neural progenitors reveals a dual
role for Pax6, in which it activates the neuronal (ectodermal) genes while concurrently represses the mesodermal and
endodermal genes, thereby ensuring the unidirectionality of lineage commitment towards neuronal differentiation. Fur-
thermore, Pax6 is critical for inducing activity of transcription factors that elicit neurogenesis and repress others that
promote non-neuronal lineages. In addition to many established downstream effectors, Pax6 directly binds and activates a
number of genes that are speciﬁcally expressed in neural progenitors but have not been previously implicated in neuro-
genesis. The in utero knockdown of one such gene, Ift74, during brain development impairs polarity and migration of
newborn neurons. These ﬁndings demonstrate new aspects of the gene regulatory circuitry of Pax6, revealing how it
functions to control neuronal development at multiple levels to ensure unidirectionality and proper execution of the neu-
rogenic program.
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Introduction
The paired box protein, Pax6, is a highly conserved
transcription factor of 422 amino acids comprising
two DNA-binding domains, an amino-terminal paired
domain and a homeodomain along with a carboxy-
terminal proline/serine/threonine-rich transactivation
domain [1, 2]. Pax6 was ﬁrst discovered to be required
for proper segmentation in Drosophila [3, 4] and
later shown to be essential for eye development in
Drosophila [5], a role that was further found to be
conserved in human and mouse eye development [6, 7].
During mammalian brain development, Pax6 is
expressed in a speciﬁc spatiotemporal manner and is
restricted to mainly neuronal tissues [2, 8]. Pax6 is
now established to be essential for maintaining the
pool of neural stem cells (NSCs) and thereby
regulating embryonic as well as adult neurogenesis,
as shown by its expression in neuroepithelial and
radial glial cells, which can divide symmetrically to
produce NSCs or asymmetrically to become a NSC
and a neuron [9, 10].
The discovery of a plethora of known Pax6
functions has been facilitated by various Pax6
mutants. One such very useful mutant, the small
eye (Sey) mouse mutant, contains a single-base
substitution [11], resulting in the production of a
functionally inactive and truncated Pax6 lacking
the DNA-binding homeodomain and the C-terminal
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activation domain. Importantly, the Sey mutant
mouse phenotype is similar to that of an artiﬁcially
targeted Pax6-deﬁcient mouse (Pax6− ax), showing
small eyes and numerous neural defects, including
reduced neurons in the cerebral cortex [11–13].
These phenotypic similarities in the Sey mutant
and Pax6− ax substantiate the use of Sey homozygous
mutant mice as Pax6-null mutants. It was further
shown that Sey mutant embryonic stem (ES)
cells generate misspeciﬁed neurons that undergo
death because of high expression of the neurotrophin
receptor p75NTR [14].
It is well established that Pax6 is crucial for the
development of the central nervous system, eyes, nose,
pancreas and pituitary gland [13, 15, 16]. Recent
studies have shown that Pax6 functions upstream of
gene networks involved in brain patterning, neuronal
migration and neural circuit formation [17]. Despite the
established role of Pax6 in neurogenesis, its genomic
targets, their chromatin status and its cooperativity with
other transcription factors during neurogenesis remain
unclear. Furthermore, while a number of players
functioning downstream of Pax6 have been identiﬁed,
these are not enough to explain the plethora of func-
tions Pax6 is known for. Here we reveal that in neural
progenitors, Pax6 binds a large number of gene pro-
moters that exhibit epigenetic state that is hallmark of
open chromatin. Many Pax6-bound promoters are also
targeted by Sox2 and functionally cooperate in gene
regulation underlying neuronal speciﬁcation. Pax6
directly binds and silences genes important for meso-
derm and endoderm development as they get de-
repressed in progenitors lacking Pax6. In addition,
Pax6 targets that are downregulated in mutant pro-
genitors are known to be critically involved in neuronal
development. Pax6-driven gene-expression program
further induces activity of neurogenic transcription
factors and repress others that promote non-neuronal
lineages. Importantly, our analysis also revealed a
number of Pax6-induced genes that are highly expressed
during brain development but their function has not yet
been explored during neurogenesis. Here we show that
one such gene, Ift74, which is directly bound and acti-
vated by Pax6 in NP cells, is required for the proper
migration of newborn neurons. Furthermore, our ana-
lysis revealed that Pax6 directly targets the promoter of
Notch signaling components and induces their expres-
sion, which then further contribute to Ift74 expression.
These observations reveal the manner by which Pax6
controls multiple components of the network under-
lying neuronal development and uncovers Ift74 as a
novel regulator of neurogenesis.
Results
Pax6 binds to a number of gene promoters in neural
progenitors cells
We ﬁrst determined the expression patterns of Pax6
in various embryonic tissues and cortical layers. As
shown previously, Pax6 is speciﬁcally highly expressed
in ventricular zone (VZ) and is gradually lost as cells
progress through the subventricular zone (SVZ) to the
cortical plate (CP; Supplementary Figure S1A). An
analysis of other ectoderm (epidermis), mesoderm
(heart and mouse embryonic ﬁbroblasts) and endo-
derm tissues (lung and pancreas) showed relative
absence of Pax6 expression, with the exception of the
pancreas that exhibited low levels of Pax6, conﬁrming
previous reports [18] (Supplementary Figure S1A). We
next use a highly reﬁned and established differentiation
model of neurogenesis, in which mouse ES cells ﬁrst
differentiate into Pax6-positive NP (radial glial-like)
cells (also referred as celllular aggregates, in short
CA_D8) and subsequently into terminally differ-
entiated glutamatergic pyramidal neurons (TN) with
high purity (495%) and synchrony and is known to
closely recapitulate the stages of embryonic neuro-
genesis [19–21]. The expression analysis of Pax6 in this
system revealed its highest expression in cellular
aggregate cells, thereby presenting a system for
investigating Pax6 function in vitro (Supplementary
Figure S1B).
To shed light on Pax6 function, we performed Pax6
chromatin immunoprecipitation (ChIP) in NPs and
investigated its genome-wide binding pattern using a
previously described ChIP-chip platform in biological
replicates [22]. These arrays cover 10% of the mouse
genome, including all well-annotated promoters, sev-
eral large multigene loci and the complete chromosome
19 [23]. The visual inspection of the genomic regions
suggested that Pax6 is targeted to distinct genomic sites
and also occupies a number of promoters (n = 5086,
promoter enrichment 40.25; Figure 1a and b,
Supplementary Figure S1C and D, Supplementary
Table S1). A comprehensive and unbiased analysis of
Pax6 binding along the fully tiled chromosome 19
revealed its relatively high enrichment at promoters
(Figure 1c). These observations were validated at
selected gene promoters in independent ChIP assays
(Figure 1d). Such targeting of Pax6 to gene promoters
prompted us to investigate its relationship with the
chromatin state of target sites and the transcriptional
states of associated genes at the progenitor stage.
We analyzed the ChIP-seq data sets for RNA
Pol II, H3K4me2, which is an established active
Uncovering Pax6-dependent gene-expression program
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Figure 1 Pax6 targets many gene promoters that largely exhibit an active chromatin state. (a, b) Representative examples of
genome browser tracks showing speciﬁc occupancies of Pax6 at promoter and its relative de-enrichment at other regions
of a selected gene (Itprip-A, Incenp-B). UCSC browser tracks from ChIP-seq datasets for H3K4me2, H3K27me3 and RNA Pol II
as well as RNA-seq from neural progenitor cells are also shown. (c) Density plot showing genome-wide enrichment of Pax6 at
promoters compared with other genomic regions on chromosome 19. To calculate the relative enrichment for each region, Pax6
enrichment was normalized with respect to the total size of that region. (d) ChIP-quantitative PCR validations of selected target
genes showing the enrichment of Pax6 at their promoters. Pax6 and Nes are used as a positive control while intergenic region is a
non-target (negative) control. Error bars reﬂect s.d. Statistical signiﬁcance were calculated with an unpaired t-test (*Po0.05;
**Po0.01; ***Po0.001; ****Po0.0001). (e) Bar plot showing Pearson correlation coefﬁcients between Pax6 occupancy and
H3K4me2, H3K27me3 and RNA Poll II RNA levels. (f) Heat map showing a comparison of Pax6 occupancy with H3K4me2,
H3K27me3 and RNA Poll II RNA levels. Red indicates high values and blue low values. (g) Scatter plot comparing enrichment of
Pax6 occupancy at promoters with enrichments of RNA Pol II, H3K4me2 and H3K27me3 in the same in vitro differentiation
system. Each dot represents a promoter and x axis shows the enrichment of Pax6, while y axis represents enrichment of RNA
Pol II, H3K4me2 or H3K27me3. Higher density of data points is represented as dark blue, while relatively less density is shown as
light green.
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histone modiﬁcation, and the Polycomb group repres-
sive mark, H3K27me3, at the NP stage in the same
differentiation system, and correlated these data with
Pax6 occupancy at the target gene promoters (Figure
1e and f). Further analysis showed that Pax6 occu-
pancy was most strongly correlated with the active
mark H3K4me2 (R2 = 0.64; Figure 1e). In addition,
a large number of Pax6-bound promoters were RNA
Pol II bound (R2 = 0.44) and actively transcribed
(R2 = 0.57; Figure 1e). Furthermore, Pax6 target pro-
moters were mostly devoid of the repressive mark
H3K27me3 (R2 = 0.13; Figure 1e). Heat map visuali-
zation at promoters supported these observations,
revealing that the majority of Pax6-bound genes dis-
played the H3K4me2 mark, a signiﬁcant fraction of
which were Pol II bound and actively transcribed
(Figure 1f). Furthermore, comparison of Pax6 occu-
pancy at promoters with enrichment of RNA Pol II,
H3K4me2 and H3K27me3 in the same differentiation
system showed similar patterns (Figure 1g). A com-
parison with promoter targets of Pax6 recently identi-
ﬁed by ChIP-seq assay in E12.5 forebrain tissue [24]
showed that out of 240 promoter targets discovered in
this study, 141 promoters were also detected as Pax6
targets in our study (data not shown), supporting the
comprehensiveness of our data.
Pax6 targets are misregulated in Pax6 mutant NPs
To further investigate the genes under the direct
transcriptional control of Pax6, we differentiated Pax6
mutant ES cells (isolated from the blastocysts of
homozygous Sey mutants, referred to thereafter
as ‘mutant cells’) [14] into NPs and performed
genome-wide transcriptome proﬁling. Sey mutant ES
cells generate misspeciﬁed neurons that undergo death
owing to high expression of the neurotrophin receptor
p75NTR [14]. Comparing the transcriptome of Sey
mutant cells with that of wild-type (WT) NP cells
revealed 675 differentially downregulated and 623
differentially upregulated genes exhibiting enrichment
for the nervous system development and metabolism
related gene ontologies (GO), respectively (Figure 2a,
Supplementary Figure S2A and B and Supplementary
Table S2). Promoters of most of the genes
downregulated in mutant progenitors were bound by
Pax6 and very highly expressed in the WT progenitors,
suggesting their robust transcription in the presence of
Pax6 (Figure 2b and c). By directly comparing
Pax6 binding at promoters to the transcriptional
changes in mutant progenitors, we found that nearly all
differentially expressed gene promoters (90%) were
Pax6 bound (promoter enrichment40) in the WT cells
(Figure 2d, left bar plots; Supplementary Figure S2C)
(hypergeometric P-value, upregulated genes:
1.71e-265; downregulated genes: 0). To retain only
those target promoters that were highly bound by
Pax6, we increased the cutoff to a higher level
(promoter enrichment 40.25) for Pax6 enrichment,
which revealed 406 downregulated and 249
upregulated genes (Figure 2d and e; hypergeometric
P-value, upregulated genes: 1.70e-22; downregulated
genes: 1.05e-99). The observation that a large fraction
of genes downregulated in the mutant progenitors were
highly enriched for Pax6 in the WT cells (n = 406) is
consistent with our previous observation that
the majority of Pax6 targets were highly expressed in
theWTNPs (Figure 2b and c). Interestingly, during the
differentiation of ES cells into neurons, a large number
of Pax6-bound/mutant-downregulated and Pax6-
bound/mutant-upregulated genes were either majorly
expressed and repressed in the NPs or an early neuro-
genesis stage, respectively (Figure 2f and g). In sum-
mary, Pax6 directly binds at the regulatory elements of
many genes to govern their proper transcriptional
dynamics during neuronal development.
Pax6 activates neuronal development genes and
represses genes from other lineages
We next performed a GO enrichment analysis for
genes that are Pax6-bound (promoter enrichment
40.25) and differentially expressed between the
WT and mutant NPs. Genes bound by Pax6 and
downregulated in mutant cells were exclusively
enriched for neuronal development (Figure 3a).
Interestingly, genes bound by Pax6 and upregulated
in mutant progenitors showed enrichment for
terms related to mesoderm (cardiovascular system
development) and endoderm (for example, respiratory
system development) development (Figure 3b).
Considering these GO term enrichments, we further
analyzed expression of these Pax6-bound differentially
expressed genes in representative embryonic tissues
from the three lineages. A majority of downregulated
genes were expressed in the three layers of the
embryonic cortex (VZ, SVZ and CP) [25], while
upregulated genes were much higher expressed in
tissues from mesoderm (heart and mouse embryonic
ﬁbroblast) [26, 27] and endoderm (lung and pancreas)
lineages [28, 29] (Figure 3c and d). Furthermore,
Pax6-bound upregulated and downregulated
transcription factor genes also showed similar patterns
in different lineages, as well as during in vitro neuro-
genesis where downregulated factors are mainly
expressed in NPs or an early neurogenesis stage while
Uncovering Pax6-dependent gene-expression program
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upregulated factors show high expression in other
lineages and ES cells (Figure 3e and f and
Supplementary Figure S3A). To further substantiate
these observations, we performed enrichment analysis
on bound and differentially expressed genes based on
known phenotypes associated with these genes.
The downregulated genes were signiﬁcantly associated
with phenotypes related to brain development
(Figure 3g), while upregulated genes were linked to
phenotypes related to abnormal development of
various mesodermal or endodermal tissues (Figure 3h).
This further substantiates our previous observations
and also provides additional insights into how
Pax6 contributes to the gene expression program
underlying neurogenesis.
To further uncover other aspects of the
Pax6-dependent regulatory network, we performed a
signaling pathway enrichment analysis. Genes
regulated by Notch signaling, a pathway that is
established to be critical for self-renewal of NSCs, were
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Figure 2 Pax6 targets are misregulated in the absence of Pax6. (a) Volcano plot showing changes in expression of genes in WT
and Pax6 mutant (mutant). x axis represents fold change in log2 scale between WT and mutant, and the y axis shows level of
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plot to show the WT expression of upregulated and downregulated genes shown in b. y axis represents the density while x axis
represents the expression levels. (d) Stacked bar plots showing that the substantial subset of differentially regulated genes in
Pax6 mutants are Pax6 targets (two different Pax6 promoter enrichment cutoff: 40 (low stringency, left panel), 40.25 (high
stringency, right panel). (e) Volcano plot as described in a but highlighting only upregulated (red dots) and downregulated (green
dots) genes that are Pax6 targets in WT cells. (f, g) Heat maps showing the expression in ES, CA, N_12h (neurons at 12 h), N_D1
(day 1 neurons) and N_D10 (neurons at day 10) of Pax6-bound genes that are signiﬁcantly downregulated (f) and upregulated (g)
in Pax6 mutant progenitors. Line plots above the heat maps show expression of Pax6 in the same stages.
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most highly enriched among the Pax6-target
mutant-downregulated genes [30–32] (Figure 3i
and j). This was followed by the Hedgehog signaling
pathway, which is also shown to be important
for speciﬁcation of NPs [33] (Figure 3i and
Supplementary Figure S3B). By contrast, Pax6-target
mutant-upregulated genes showed enrichment for FGF
signaling, that has been shown to be involved in
mesodermal and endodermal speciﬁcation [34–36]
(Supplementary Figure S3C and D). Although
previously Pax6 has been indirectly implicated in the
control of Notch pathway [10], our analysis revealed
that Pax6 directly binds at the promoters of a large
number of genes associated with Notch signaling.
Furthermore, these genes were downregulated in
mutant NPs, indicating that Pax6 has a direct role
in the activation of Notch signaling in NP cells
(Figure 3j). This targeting by Pax6 at Notch signaling
components provides potential mechanism regarding
how this master transcription factor acts at multiple
levels to deﬁne progenitor identity and differentiation
towards neurons. Overall, these analyses identify a dual
role for Pax6, in which it mediates the activation of
neuronal (ectodermal) genes while concurrently
represses the mesodermal and endodermal genes.
Pax6 inﬂuences transcription factor network to confer
unidirectionality towards neuronal differentiation
On the basis of our observations that Pax6 mutant
cells showed upregulation of non-neuronal and
downregulation of neuronal genes, we next probed
whether activities of any particular transcriptional
factors are altered in the absence of Pax6 that in
turns could explain part of gene-expression program
alterations. Towards this we applied integrated system
for motif activity response analysis (ISMARA), which
predicts the transcription factors that can potentially
regulate the differentially expressed genes on the basis
of binding motifs at the promoters of these genes
[37,38]. ISMARA analysis predicted a number of
transcription factors whose activity signiﬁcantly
changed in Pax6 mutant NPs. This included Pax6 and
Sox2 that showed downregulation in their activity
(Figure 4a–f). In line with these ﬁndings, ISMARA
predicted targets of Pax6 and Sox2 were also found to
be signiﬁcantly downregulated in Sey cells (Figure 4b
and e).
Furthermore, ISMARA also predicted interaction
networks of Pax6 and Sox2 with other transcription
factors many of which are known to be important
for neurogenesis (Figure 4c and f). Two transcription
factors, TFAP2B and TCF4, were commonly identiﬁed
in both Pax6 and Sox2 interaction networks (Figure 4c,
f and g). Surprisingly, predicted targets of TFAP2B or
TCF4 were highly enriched for genes related to
neurogenesis (Supplementary Table S3). The role
of TFAP2B in neuronal development as well as its
interaction with Pax6 and Sox2 is unknown, however,
our prediction provides potential insights of how
cooperativity between different transcription factors
contributes to neurogenesis. Targets of TFAP2B were
also very signiﬁcantly downregulated in Sey cells
(Figure 4h) and network analysis further predicted its
interaction with Pax6 as well as Sox2 in addition to
many other interesting factors known to be required for
neurogenesis (for example, Zeb1; Figure 4i). Overall,
these observations suggest a cooperative function of
transcription factors Pax6, Sox2 and TFAP2B in WT
progenitors in gene activation as their activity and
consequently their targets are downregulated in
mutant cells.
Furthermore, ISMARA analysis also revealed
upregulation in the activity of a number of
transcription factors that are known to be important
for non-neuronal lineages such as T (brachyury),
Hnf1a and members of the Myf family (Figure 4j–r).
Brachyury is an established mesoderm transcription
factor [37,38], while Hnf1a is critical for liver differ-
entiation [39] and Myf family of transcription factors
are known to be crucial for heart development [37].
Target genes of these three transcription factors were
signiﬁcantly upregulated in mutant cells (Figure 4k, n
Figure 3 Pax6 activates neuronal genes while repressing mesodermal and endodermal genes. (a, b) Bar and line plots showing GO term
enrichment analysis of Pax6-bound genes that were downregulated (a) or upregulated (b) in Pax6 mutant progenitors. Bar plots show
number of genes for each enriched GO term (main x axis), and lines represent P-values for corresponding GO terms (alternate x axis).
(c, d) Expression of upregulated (c) and downregulated (d) genes in tissues from different germ layers. (e, f) Same as in c and d but only
for differentially expressed transcription factors. (g, h) Same as in a and b but an enrichment analysis was performed for mouse
phenotypes enriched in Pax6-bound downregulated (g) and upregulated (h) genes. (i) Similar bar plot as in a, but the enrichment analysis
was performed for signaling pathways using Genomatix. (j) Scatter plot showing changes in expression of core Notch signaling pathway
components in WT and Pax6mutant cells and their enrichments for Pax6. The x axis represents the fold change (log2) between WT and
Pax6 mutant cells, and the y axis shows Pax6 enrichment.
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and q). GO enrichment analysis showed that these
target genes are involved in the development and
function of non-neuronal tissues (Supplementary Table
S3). Furthermore, the network for each of these factors
mostly consisted of a non-overlapping set of tran-
scription factors (Figure 4l, o and r). Overall, these
ﬁndings show that Pax6-dependent gene regulatory
circuitry induces activity of transcription factors that
induce neurogenesis and repress others that promote
non-neuronal lineage.
Sox2 targets a large number of Pax6-bound gene
promoters
We were intrigued by our observations that Sox2
activity is signiﬁcantly reduced in Pax6 mutant NP
cells. Both Sox2 and Pax6 are known to be important
for the maintenance of the proliferative and
developmental potential of NSCs [40]. Although it is
known that Pax6 and Sox2 form a complex [41, 42], it
remains to be investigated whether they function
together in gene regulation at the same targets sites in
the genome. We, therefore, compared our list of Pax6
target promoters with that of Sox2-bound promoters in
NP cells derived from mouse ES cells in a previous
study [43]. This analysis revealed that both Pax6 and
Sox2 co-occupy a noticeable set of gene promoters,
suggesting a potential cooperativity between these two
transcription factors in gene regulation (Figure 5a and
Supplementary Figure S4A; hypergeometric P-value:
1.28e-65). We next classiﬁed the genes encoding
transcription factors, which were either expressed
or repressed in the NPs in vivo (based on the
transcriptome analysis of the E14.5 VZ cells) [25] and
analyzed their promoter occupancies by Pax6 and
Sox2. Pax6 and Sox2 were bound at the promoters of
~ 40% of the transcription factors expressed in the VZ
(Figure 5b; hypergeometric P-value: 1.04e-22,
Pax6 and 6.92e-27, Sox2). To our surprise, of the
transcription factors that were not transcribed in
the VZ, Pax6 occupied nearly 3.5-fold more targets
compared with Sox2 (~37%, Hypergeometric P-value:
1.02e-20 Pax6, versus ~ 10%, Hypergeometric
P-value: 1 Sox2; Figure 5c). In line with our previous
observations, these results also suggest that Pax6-Sox2
complex preferentially bind to expressed transcription
factors while without Sox2, Pax6 acts as a repressor.
We were next curious to investigate whether the
expression of Pax6 only bound target genes differs with
respect to those bound by both Pax6 and Sox2 in WT
and Pax6 mutant progenitors. Interestingly, genes
bound by both Pax6 and Sox2 were signiﬁcantly higher
expressed in WT as compared with Pax6 alone or a
random set of genes (Figure 5d). In line with these
observations, these Pax6 and Sox2 common target
promoters show higher accessibility as compared with
Pax6 only and random promoters (Supplementary
Figure S4B). Further supporting these ﬁndings, genes
bound by both were more severely downregulated in
mutant relative to Pax6 alone bound genes (Figure 5e).
Together with previous observations, these results
argue for an active cooperativity between Pax6 and
Sox2 in regulating transcription of distinct set of genes
in NP cells.
To further delineate and substantiate the expression
dynamics of Pax6 and Sox2 targets, we explored
recently published transcriptome data sets for distinct
progenitor subpopulations (aRG, apical radial glial;
bRG, basal radial glial; IPC, intermediate progenitors)
as well as neurons from developing mouse neocortex
[44]. Comparison of NP markers in our in vitro
neuronal differentiation system and the above data sets
showed that our ES-derived progenitors are apical in
nature (Supplementary Figure S4C and D).
Further comparison revealed an interesting pattern of
expression for Pax6 only and Sox2 only bound genes
compared with Pax6 and Sox2 co-occupied genes
during neurogenesis (Figure 5f and h). The set of genes
bound by either Pax6 or Sox2 and expressed in aRG
Figure 4 Pax6 is critical for inducing activity of transcription factors that elicit neurogenesis and repress others that promote non-neuronal
lineages. (a) Pax6 motif identiﬁed by ISMARA. (b) Box plot showing expression in WT and mutant of Pax6 targets predicted by ISMARA.
(c) First-level interaction network of Pax6 and its potential targets as predicted by ISMARA. (d) Sox2 motif identiﬁed by ISMARA. (e) Box
plot showing expression in WT and mutant of Sox2 targets predicted by ISMARA. (f) First-level interaction network of Sox2 and its
potential targets as predicted by ISMARA. (g) Tfap2b motif identiﬁed by ISMARA. (h) Box plot showing expression in WT and mutant of
Tfap2b targets predicted by ISMARA. (i) First-level interaction network of Tfap2B and its potential targets as predicted by ISMARA.
(j) Brachyury (T) motif identiﬁed by ISMARA. (k) Box plot showing expression in WT and mutant of Brachyury (T) targets predicted by
ISMARA. (l) First-level interaction network of Brachyury (T) and its potential targets as predicted by ISMARA. (m) Myf family motif
identiﬁed by ISMARA. (n) Box plot showing expression in WT and mutant of Myf family targets predicted by ISMARA. (o) First-level
interaction network of Myf family and its potential targets as predicted by ISMARA. (p) Hnf1a motif identiﬁed by ISMARA. (q) Box plot
showing expression in WT and mutant of Hnf1a targets predicted by ISMARA. (r) First-level interaction network of Hnf1a and its potential
targets as predicted by ISMARA. All P-values are calculated using Wilcoxon test.
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were repressed in the immediate next stage (bRG) and
remained repressed throughout neurogenesis (cluster A
in Figure 5f and g). However, the genes bound by
either Pax6 or Sox2 and repressed in aRG showed
transcriptional activation in a stage-speciﬁc manner
during neurogenesis (cluster B, C and D Figure 5f
and g). In contrast, genes co-occupied by both tran-
scription factors and expressed (cluster A) or repressed
(cluster B) in aRG were immediately repressed or
activated in bRG, respectively, and maintained this
state throughout neurogenesis (Figure 5h). Overall,
these observations suggest that the gene regulatory
function of Pax6 at its target sites may be inﬂuenced by
co-factors such as Sox2.
We next wondered whether other transcription
factors expressed later during neurogenesis could
function at Pax6 and Sox2 target sites when Pax6 and
Sox2 are no longer available. To test this hypothesis we
chose Ascl1, which is shown to be essential for the
transition from neuronal progenitors to a neuronal
state [45, 46] and neurogenesis is severely impaired in
the absence of Ascl1 [47–49]. During neuronal
differentiation from ES cells, Pax6 and Sox2 are
simultaneously highly expressed in NP cells and
following onset of neurogenesis, their levels decrease
while Ascl1 levels are further increased (Supplementary
Figures S4E). Using a recently published genome-wide
binding data set for Ascl1 during neurogenesis [50], we
found that Ascl1 shared 44% of Pax6 (hypergeometric
P-value, 1.55e-22) and 25% (hypergeometric P-value,
3.24e-13) of Sox2 targets (Figure 5i and j).
Interestingly, the targets common between Pax6, Sox2
and Ascl1 (n = 75) included classical Notch pathway
(Id1, Id2,Hey1,Hes6 and Dll1) and neuronal (Tubb2b,
Robo1, Mapt and Pcdh10) genes. We next explored
how Pax6 and Sox2 targets that are also bound by
Ascl1 are expressed during in vitro neurogenesis. Heat
map visualization of these sets showed that such genes
that are bound by Pax6 and/or Sox2 and also by Ascl1
mostly maintain their transcription state as cells exit
NP state (higher Pax6/Sox2 and lower Ascl1 levels)
towards initiating neurogenesis (lower Pax6/Sox2
and higher Ascl1 levels; Figure 5k and m).
Furthermore, most of these genes acquire an opposite
expression state in terminally differentiated neurons
(no Pax6, Sox2 or Ascl1 expression). This suggests that
a distinct sets of Pax6/Sox2 target genes might be tar-
geted by other transcription factors in subsequent
stages of neurogenesis to facilitate maintenance of their
transcription state despite the later absence of Pax6/
Sox2 itself.
To further explore the functional differences
between the genes occupied by Ascl1 uniquely or Ascl1
along with Pax6 and/or Sox2, we performed a
comparative GO term analysis to reveal their possible
involvement in any speciﬁc biological processes
(Figure 5n). The set of genes that were targeted by Pax6
and Sox2 only (blue squares) were enriched for a broad
range of functions related to neural precursor or neural
tube formation, cell cycle, transcription regulation,
protein localization, metabolic processes and
chromatin organization (Figure 5n). These genes were
also enriched for functions related to neuronal
differentiation and maturation (yellow squares).
Interestingly, Ascl1 unique target genes were also
enriched for these functions (yellow squares) indicating
towards a functional takeover of neuronal
development by Ascl1 (Figure 5n). The set of genes that
were bound by Pax6/Sox2 complex and also by Ascl1
were exclusively enriched for Notch signaling and
Figure 5 Pax6 and Sox2 act cooperatively to drive neurogenesis. (a) Stacked bar plot showing percentage of overlapping Pax6 and Sox2
targets. y axis represent percentage of Pax6 and Sox2 targets. (b) Bar plot showing expressed transcription factors in VZ as well as the
ones targeted by either Pax6 or Sox2. (c) Same as in b but for not-expressed transcription factors. (d, e) Box plot showing expression and
changes in expression of Pax6 and Sox2 targets, Pax6 only targets and random genes in WT (d) and mutant progenitors (e). y axis in d
represents expression in WT cells while y axis in e shows fold change of expression between WT and mutant cells. P-value is calculated
using Wilcoxon test. (f–h) Expression of Pax6 only (f), Sox2 only (g) and Pax6 and Sox2 targets (h) during several stages of
neurogenesis. aRG, apical radial glial; bRG, basal radial glial; IPC, intermediate progenitors. (i) Stacked bar plot showing the overlap of
Ascl1 targets with Pax6 and Sox2. y axis represent percentage of Ascl1 targets. (j) Venn diagram showing the number of overlapping
targets of Pax6, Sox2 or Ascl1. (k–m): Heat maps showing expression of Pax6 and Ascl1 common targets (k), Sox2 and Ascl1 common
targets (l) and Pax6, Sox2 and Ascl1 common targets during different steps of in vitro neurogenesis. Line plots above heat maps show
expression of Pax6, Sox2 and Ascl1 in the same stages. Fold change is with respect to CA day 8 (CA_D8). (n) Comparative GO
enrichment analysis of different set of genes represented as a network. Each square represent a GO term associated with a particular list,
while edges provide information about the list to which the particular GO term is associated. If a GO term was found to be present in all
three lists, it got connected with all three list nodes by edges. Pax6 and Sox2 target genes functions were further divided into sub-clusters
based on similar GO terms.
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neuronal differentiation (Figure 5n, red squares).
We also observed that the functional class ‘neuronal
projection’ was uniquely attributed to targets that
were also targeted by Ascl1 only (green squares;
Figure 5n), supporting its known role in early neuronal
development. Overall these data indicate that a subset
of neurogenesis-related genes that are acted upon by
Pax6 and/or Sox2 in NPs may also be targeted by other
transcription factors such as Ascl1 for gene regulation
during neuronal development.
Pax6 directly induces expression of many known and
novel NP-speciﬁc transcription factors
We next attempted to further investigate the role of
Pax6 in regulating the expression of NP-speciﬁc genes
by performing a series of stepwise analyses. First, we
selected the Pax6-bound mutant-downregulated
genes that were signiﬁcantly higher expressed in
E14.5 cortical layers compared with other tissues
(heart, embryonic ﬁbroblasts, lung and pancreas).
Then, we selected those factors that were at least
two-fold upregulated in the VZ compared with the CP
(Figure 6a). Interestingly, this ﬁnal list of 46 genes
primarily consisted of transcription factors, including
established Pax6 targets and known regulators
of NP identity (for example, Nestin, Neurog1/2,
Neurod1/4 and Notch pathway components, such as
Dll1 and Hes6; Figure 6b and Supplementary Figure
S5A). Pax6 was also bound to its own locus likely for
autoregulation as shown previously [12]. Of these 46
Pax6-target gene promoters, 17 were also co-occupied
by Sox2 (data not shown). This analysis also
identiﬁed many novel factors that have not been
previously shown to function in regulating
progenitor identity (Supplementary Figure S5B). The
expression pattern of many of these genes was further
validated by their in situ hybridization analysis in the
embryonic cortex (Figure 6c) [51]. This analysis
revealed how Pax6 functions as an upstream regulator
of many known critical neurogenesis-related tran-
scription factors, at the same time identiﬁed many
previously unknown Pax6 targets that are speciﬁcally
expressed in the cortex and warrant further
investigation.
Ift74 is a novel Pax6 target that contributes to neuronal
migration
We were next interested to deeply explore the
function of novel genes that were directly bound and
activated by Pax6 and whose expression was restricted
to NPs. We focused on Ift74 (intraﬂagellar transport
(IFT) 74 homolog), which is a component of the IFT
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Figure 6 Pax6 directly induces expression of a large number of known and novel neural progenitor-speciﬁc transcription factors.
(a) Flow chart showing the identiﬁcation of genes that are speciﬁcally upregulated in neural progenitors in vivo and are regulated
by Pax6. (b) Heat map showing the expression patterns of 46 genes identiﬁed in a. Red means high expression while blue means
lower expression. (MEF, mouse embryonic ﬁbroblast). (c) In situ hybridization images for known and novel Pax6 targets as
derived from the Allen Brain Atlas (http://developingmouse.brain-map.org/).
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complex but remains a rather uncharacterised protein
in the context of mammalian biology. Ift74 forms a
tubulin-binding module together with IFT81 that
speciﬁcally mediates transport of tubulin within the
cilium required for ciliogenesis [52]. To precisely map
the kinetics of its expression with respect to Pax6, we
analyzed their expression at various time points
during the differentiation of ES cells into neurons via a
NP state. As expected, this ﬁne time course analysis
during neuronal differentiation revealed that Pax6 was
most highly induced upon commitment to NPs and
downregulated as soon as neurogenesis progressed
(Figure 7a). Interestingly, analysis of Ift74 at same time
points showed that it reached its maximum expression
levels few hours after highest Pax6 expression, a stage
that marks the transition of NP cells to neurons, and
subsequently its expression was reduced upon neuronal
maturation (Figure 7a).
To further substantiate our observations of Ift74
induction in the context of Pax6 expression in vivo, we
next analyzed transcriptome data derived from the
three layers of the E14.5 cortex (VZ, SVZ and CP)
that showed the prominent expression of Ift74 in
the VZ of the developing mouse brain [25], which is
where Pax6 is also most highly expressed (Figure 7b
and Supplementary Figure S1A). In order to conﬁrm
the direct binding of Pax6 at the promoter of Ift74, we
performed ChIP assay in NP cells using Pax6-speciﬁc
antibody. Real-time PCR analysis conﬁrmed a high
enrichment of Pax6 at a region upstream of the
transcription start site of Ift74 gene (Figure 7c). Given
that Notch signaling is known to be essential for the
self-renewal and identity of NP cells [30–32] and Notch
effector transcription factor RBPJ showed occupancy
at Ift74 promoter in NSCs (D. Castro. Personal
communication), we studied the effects of blocking
Notch signaling on Ift74 levels. To test whether Ift74
expression is regulated by Notch pathway, we inhibited
Notch signaling using two independent inhibitors
(LY-411575 and (N-[N-(3,5-Diﬂuorophenacetyl)-L-
alanyl]-S-phenylglycine t-butyl ester (DAPT)) and
analyzed the expression of Ift74. These analyses
showed that under both inhibitor treatments, Ift74 was
signiﬁcantly downregulated (Figure 7d). In addition,
such blockage of Notch pathway also led to expected
changes in the expression of Notch signaling compo-
nents (Figure 7d) and is in agreement to previous stu-
dies [53]. Importantly, further in line with a critical role
of Notch signaling in regulating NSC self-renewal and
identity, we also found that the loss of Notch signaling
also led to signiﬁcant reduction in the expression NP
markers (Pax6 and Sox2; Figure 7d). Given these
observations, an alternative explanation for the
downregulation of Ift74 by Notch inhibitors is that the
NPs differentiate into more mature cell types that do
not express Ift74. Since our earlier observations showed
a direct induction of Notch signaling components by
Pax6, the decrease in Ift74 expression upon Notch
inhibition also suggests a potential functional coop-
erativity between Pax6 and Notch signaling in reg-
ulating the downstream gene-expression program.
Given the known function of Ift74 in the transport of
tubulin within the cilium that is required for
ciliogenesis [52], we were tempted to investigate
whether its induction by Pax6 serves to promote
neuronal migration during later stages of neurogenesis.
Towards this, we performed in utero electroporation
using a plasmid encoding a tested shRNA against Ift74
(Supplementary Figure S6A) at embryonic stage E12.5
and sacriﬁced the embryos for characterization at
E16.5. Depletion of Ift74 via this shRNA in vitro does
not result in cell death or impaired the cell-cycle
progression (Supplementary Figure S6B and SC). In
the control shRNA electroporated brains, the majority
of electroporated cells were detected in the cortical
plate and very few such cells were retained in the
ventricular zone, reﬂecting proper cortical migration
of newborn neurons (Figure 7e). Ift74 shRNA
electroporated brains, in contrast, showed a distinct
phenotype where the majority of Ift74-depleted cells
failed to migrate to the cortical plate (Figure 7e).
Having observed such mislocalization of Ift74-depleted
cells we were interested to uncover at which stage
of neurogenesis these cells are perturbed. A staining of
electroporated brain sections with Pax6 (Figure 7f) and
Tbr2 (Figure 7g) showed no defect in the early
neuronal maturation processes since the percentage of
shIft74 and non-targeting control electroporated cells
showing similar Pax6 and Tbr2 expression. We next
assessed whether Ift74-depleted cells migrating above
the Tbr2 layer, express neuronal markers. A co-
staining with Tuj1 revealed a clear overlap with shIft74
electroporated cells (Figure 7h) indicating that these
cells achieve neuronal identity but fail to fully migrate
towards upper cortical layers. Although having a closer
look into these images, many cells appeared to have
multiple small processes and suggested that in the
absence of Ift74, cells accumulate in the multipolar
phase in SVZ/intermediate zone (IZ) region instead of
migrating to CP.
For a detailed look into this phenomenon we took
images at higher magniﬁcation of non-targeting con-
trol and shIft74 electroporated cells from different
cortical layers and further investigated the
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morphological appearance of such cells (Figure 7i–k).
We observed that, in the ventricular/subventricular
zone, control as well as Ift74-deﬁcient cells displayed a
comparable elongated polar appearance (Figure 7i). In
the IZ, cells electroporated with either non-targeting
control or shIft74 again looked very similar and dis-
played a more roundish multipolar morphology
(Figure 7j). However, while control cells subsequently
transform back into a bipolar shape while migrating
towards cortical plate, Ift74-depleted cells failed to do
so and reside as multipolar cells in the IZ (Figure 7k).
These observations suggest that cells deﬁcient for Ift74
are able to normally differentiate until the stage of
immature projection neurons that enter the IZ and
become multipolar but are not able to reorient into
elongated, bipolar shape essential for proper migration
to the cortical layer. Since neuronal migration is driven
via epithelial to mesenchymal transition (EMT)-like
mechanisms [54], we analyzed the role of Ift74 in cel-
lular migration using mammary epithelial cells as an
established cellular model of EMT [54–56]. We induced
EMT and at the same time transfected shRNA against
Ift74 in the epithelial cells and then measured cellular
migration 4 days later. We ﬁnd that shRNA-mediated
depletion of Ift74 led to a signiﬁcant reduction in the
migration capacity of these cells (Supplementary
Figure S6D and E). Taken together, these
observations suggest that Pax6 and Notch signaling
may cooperate in regulating gene expression (for
example, of Ift74) as well as identify Ift74 as a new
Pax6 target that potentially has a role during neuro-
genesis likely via contributing to the migration of
newborn neurons.
Discussion
Pax6 is a known master regulator of NP identity
[8, 9, 15, 16, 57–63]. In this study, we attempted to
uncover genes under the transcriptional control of
Pax6 in NPs and identiﬁed downstream transcription
factors that contribute to neurogenesis. We found that
in NPs, Pax6 is targeted to many promoters that
showed a distinct epigenetic state of open chromatin.
Interestingly, many Pax6 sites are also occupied by
Sox2, suggesting that they function together in gene
regulation. Pax6 deﬁciency causes defects in the
expression of its target genes, linking its binding to a
function in transcriptional regulation. Strikingly, our
analysis also revealed a dual role for Pax6, in which it
activates the neuronal (ectodermal) genes while con-
currently represses the mesodermal and endodermal
genes. Importantly, Pax6 also directly induces the
expression of a number of known as well as novel genes
including transcription factors that are speciﬁcally
Figure 7 Ift74 contributes to neuronal migration. (a) Expression of Pax6 and Ift74 during neuronal differentiation of ES cells derived by
real time quantitative PCR (RT-qPCR). Expression is shown for various stages of neuronal differentiation (ES cells, CA at day 4 before
adding RA (CA d4), CA at day 8 (CA_D8)) and various time points during neurogenesis (TN at 12 h and day 1, 2, 3, 5, 7 and 10). mRNA
expression is normalized to the housekeeping gene Rpl19 (n = 3, error bars show S.E.M). (b) Expression of Ift74 (in RPKM) in VZ, SVZ,
and CP dissected from mouse embryos at E14.5 derived by RNA-sequencing (GSE30765). (c) Pax6 ChIP-qPCRs to validate Pax6
binding at the promoter (−200± 0 bp region) of Ift74 at CA day 8 (CA_d8) (n = 3, error bars shown as s.e.m.). Average enrichments are
plotted normalized to input and further to an intergenic control region (control). (d) Fold change in mRNA levels in CA_d8 cells treated
with γ-secretase inhibitor as compared with non-treated cells. ES cells were induced to undergo neuronal differentiation and treated every
other day with 5 μM N-[N-(3,5-Diﬂuorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) (n = 5), 3 nM LY-411575 (n = 3) or
dimethylsulfoxide as control from CA_d4 stage onwards. Expression of the shown genes were normalized to Rpl19 levels (ΔCT) and fold
change with respect to the control is plotted (error bars show s.e.m.). Statistical signiﬁcance were calculated with an unpaired t-test
(*Po0.05; **Po0.01; ***Po0.001; ****Po0.0001). (e) Left panel: representative immunoﬂuorescence images from coronal brain
sections at E16.5 stained for DNA using Hoechst (blue). Green ﬂuorescent protein (GFP; green) marks shIft74 or non-targeting control
electroporated cells; brains were electroporated at E12.5 and analyzed after 4 days. Scale bar: 100 μm. Right panel: quantiﬁcations of
ﬂuorescence signal in the GFP channel using ImageJ in the lower Hoechst dense region (VZ/SVZ), the intermediate less DNA dense
region (IZ) and the upper Hoechst dense region (CP). Error bars reﬂect s.e.m. of three representative regions from two independently
electroporated brains. (f) Representative immunoﬂuorescence images of cortical brain slices electroporated at E12.5 with non-targeting
control or shIft74 and analyzed at E16.5. GFP (green) and PAX6 (red) stain is represented and the scale bar: 100 μm. All GFP-positive
cells have been counted and the percentage of cells that also displayed PAX6 signal is plotted on the y axis n = 2, error bars show s.e.
m.). (g) Same as in f but co-stained with TBR2 (red) and accordingly quantiﬁed as above for TBR2-positive electroporated cells. (h)
Representative immunoﬂuorescence images of cortical brain slices electroporated at E12.5 with shIft74 and analyzed at E16.5. GFP
(green), TUJ1 (red) and DNA (blue) stain is represented and the scale bar: 100 μm. (i–k) GFP images to analyze cell shape and polarity
for non-targeting control and shIft74 electroporated brains in VZ/SVZ (i), IZ (j) and CP (k) region. White arrowheads point to multipolar
roundish cells in the IZ and bipolar cells in VZ, SVZ and CP of non-targeting control and shIft74 electroporated brains. Scale bar: 50 μm.
On the right side of each image representative thresholded cells of the particular layer are represented.
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expressed in NPs. We further show that one of the
novel Pax6 target gene, Ift74, may have an important
role during neurogenesis, likely via regulating migra-
tion of newborn neurons. Furthermore, our results also
provide indication that Notch signaling contributes to
the transcriptional induction of Ift74 in NPs. Interest-
ingly, Pax6 also directly binds at the promoters of
many Notch signaling components and functions in
their activation, suggesting the functional cooperativity
between Pax6 and Notch signaling in regulating a
downstream gene-expression program. Overall, our
ﬁndings reveal how Pax6 regulates the gene-expression
program at multiple levels to ensure proper execution
of the neurogenic program, and at the same time
ensures the unidirectionality of neuronal differentia-
tion (Figure 8).
The complexity of Pax6 function has been suggested
to arise from its interaction with various transcription
factors to synergistically regulate target gene
expression. In lens development, the transcriptional
regulation of several crystallin genes by Pax6 is
achieved in coordination with other transcription
factors, such as Sox2 and Maf [64, 65]. Pax6 has
been shown to form a complex with Sox2 to
transcriptionally activate the δ-crystallin gene [41].
Sox2 is of further relevance because it is expressed
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in the developing mouse central nervous system from
an early stage [66] and regulates the expression of
ﬁbroblast growth factor 4 (Fgf4) and Nestin, which are
important in maintaining NSCs [67]. Our ISMARA
analysis showed that the activity of Sox2 was
signiﬁcantly reduced in Pax6 mutant NP cells.
Moreover, Sox2 co-occurred with Pax6 at many
promoters in NP cells. Furthermore, these data also
reveal that critical NP genes, such as Nestin, are
co-regulated by Pax6 and Sox2. We also observed that
the target genes co-occupied by Pax6 and Sox2 are
expressed at higher levels, including those encoding
important transcription factors, as compared with
Pax6 only targets. These ﬁndings highlight the
importance of the interplay between Pax6 and Sox2
in cooperative transcriptional regulation during
neurogenesis, and at the same time also imply that
critical neurogenesis genes may require co-activation
by more than one stage-speciﬁc transcription factor.
Furthermore, these observations also indicate that the
gene regulatory potential of Pax6 may be determined
by its partners and in this speciﬁc case, Sox2 occupancy
drives it more towards a transcription activating role.
We also observed distinct expression dynamics of
Pax6 and Sox2 unique target genes compared with
those co-occupied by both factors during subsequent
stages of neurogenesis. The genes bound by either Pax6
or Sox2 and expressed in aRG showed transcriptional
activation in a stage-speciﬁc manner during
neurogenesis where different gene-sets were found to be
expressed in bRG, IPC and neurons. It may reﬂect
availability of distinct factors or signaling pathways
that become active at each of these stages to induce a
set of genes critical for that particular stage of
neuronal differentiation. On the other hand, all genes
co-occupied by both Pax6 and Sox2 acquired changes
in their expression state immediately after transition
from aRG to bRG and this transcription state was
maintained during later stages. This may also
imply that genes that are required to be immediately
switched on or off during differentiation of NPs may in
some way beneﬁt from being targeted by both Pax6
and Sox2.
Pax6 is believed to exert its effects by regulating
critical downstream effectors during neurogenesis. A
number of such examples have already been described,
such as Fabp7, Neurog2, p27kip1, cell adhesion
molecules (for example, L1 optimedin A, R-cadherin,
δ-catenin and tenascin C), patterning molecules
(for example, secreted frizzled-related protein 2
(sFRP2) and T-cell factor 4 (Tcf4)), Nkx2.2, Hoxd4, as
well as other transcription factors, including Nﬁa,
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Figure 8 Pax6 regulates the gene-expression program at multiple levels to promote neuronal differentiation. Pax6 mediates the
activation of neuronal (ectodermal) genes while concurrently represses the mesodermal and endodermal genes, thereby
ensuring the unidirectionality of lineage commitment towards neuronal differentiation. Pax6 directly binds and activates
expression of critical transcription factors and components of signaling pathways, all of which then function in concert to
orchestrate downstream gene-expression program that drives neurogenesis.
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AP-2γ, NeuroD6, Neurog2, Tbr2, and Bhlhb5 [9, 15,
16, 57–63, 68, 69]. Our study is in line with the
previous reports of a direct regulation of neurogenic
transcription factors by Pax6 [17]. Importantly, our
data also identiﬁed several additional genes including
transcription factors that are directly induced by Pax6
in NP cells but have not been studied in the context of
neuronal development (for example, Bazb2, Hmgn3,
Peli2,Vit). Furthermore, although the role of Pax6 and
Notch signaling in neuronal development is known for
long, our data provide the ﬁrst evidence that Pax6 also
promotes Notch signaling by directly inducing the
expression of critical components of this pathway
(Figure 8).
Our data suggest that although Pax6 activates genes
related to neuronal development, it represses the
transcription of mesodermal and endodermal genes.
Furthermore, ISMARA analysis also showed
that Pax6 is required for the induction of transcription
factors and their targets that elicit neurogenesis
(for example, Sox2 and Tfap2b) and repress others
that promote non-neuronal lineages (for example,
Brachyury, Hnf1a and Myf family of transcription
factors). These observations strongly imply that Pax6-
driven gene regulatory program functions to ensure the
unidirectionality towards neuronal differentiation.
During neurogenesis, NP cells undergo massive
morphological and spatial changes that are tightly
linked to cytoskeleton changes. For example, neocor-
tical neurons arise by asymmetric division of radial glia
progenitors (RG) in the VZ with a bipolar morphology
and gradually become multipolar as they reach SVZ/IZ
zone and move erratically. Subsequently, these cells
undergo a multipolar to bipolar transition and move
rapidly along RGs to the top of CP [70]. Defective
ciliogenesis has been shown to accompany defects in
neuronal migration in human ciliopathy phenotypes
such as Meckel–Gruber syndrome [71]. We ﬁnd that
one of the Pax6-induced genes, Ift74, is highly expres-
sed in NP cells as compared with other cell types. It has
been shown in human cells that Ift74 and Ift81 build a
tubulin-binding module whose binding to tubulin is
important for ciliogenesis [52]. Depletion of Ift74 by in
utero electroporation during cortical development led
to a retention of migrating cells in the lower layer of the
cortex. Furthermore, some cells showed multiple small
processes, indicating that the knockdown cells are in
the multipolar phase in SVZ/IZ region and fail to
migrate to the CP. These observations collectively
suggest that the regulation of ciliogenesis and/or
axonogenesis via Ift74 might be essential for cortical
development. Moreover, Ift74-depleted cells showed
signiﬁcantly reduced migration capacity during
EMT in vitro. Importantly, as Notch signaling is
known to be essential for proper radial migration of
cortical neurons [72] and since we also found that
Notch signaling is required for proper transcriptional
induction of Ift74, it is likely that the previously
observed defects in neuronal migration in the absence
of Notch signaling are, at least in part, contributed by a
loss of Ift74 expression.
Taken together our ﬁndings provide novel insights
into genomic localization and gene regulatory function
of Pax6 during cortical development. Here we show that
Pax6 targets a distinct class of epigenetically marked
gene promoters, a number of which are co-occupied by
other critical transcription factors such as Sox2. Our
results suggest a model for a dual function of Pax6 upon
neuronal commitment where it mediates the activation
of neuronal (ectodermal) genes while concurrently
represses the mesodermal and endodermal genes to
ensure the unidirectionality towards neuronal differ-
entiation. In addition, Pax6 also induces critical signal-
ing pathways that further work together with Pax6 in
guiding critical neurogenic events. Our ﬁndings high-
light how the gene regulatory circuitry organized by a
single factor is able to contribute to neuronal develop-
ment at multiple levels. In addition to many established
downstream effectors, this study has identiﬁed many
novel targets that are bound and activated by Pax6 and
warrant further investigation in cortical development.
The in utero knockdown of one such gene, Ift74, during
brain development resulted in impaired neuronal
polarity and migration of newborn neurons. Overall,
these ﬁndings reveal how Pax6 functions in the control
of neuronal development at multiple levels to ensure
unidirectionality and proper execution of the neurogenic
program.
Materials and Methods
Cell culture
WT and Sey ES cells derived from blastocysts (3.5 PC) of
mixed 129-C57Bl/6 background (called 159.2) were cultured and
differentiated as previously described [19].
Quantitative RT-PCR
Total RNA isolation, cDNA synthesis and quantitative
RT-PCR were performed according to the manufacturer’s
(Qiagen, Hilden, Germany) guidelines. Primer sequences will be
provided upon request.
ChIP assay
ChIP experiments were performed as previously described
[73]. In brief, crosslinked chromatin was sonicated to achieve an
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average fragment size of 200 bp. Starting with 70 μg of
chromatin and 5 μg of antibodies, 1 μl of ChIP material and 1 μl
of input material were used for quantitative real-time PCR using
speciﬁc primers. Primers covering an intergenic region were used
as the control. The efﬁciencies of the PCR ampliﬁcations were
normalized to those of the PCR products of the intergenic
regions. The following antibodies were used: anti-Pax6
(Covance, Munich, Germany), anti-RNA Pol II: N-20 (Santa
Crutz, Heidelberg, Germany), anti-H3K4me2: 07–030 (Milli-
pore, Darmstadt, Germany), and anti-H3K27me3. Primer
sequences will be available upon request. The ChIP material for
Pax6 was used for ChIP-chip and for H3K4me2 and H3K27me3
was used for ChIP-seq as described later.
In utero electroporation and imaging
The plasmids containing control shRNA (5ʹ-CAACA
AGATGAAGAGCACCAA-3ʹ) or shIft74 shRNA (5ʹ-CGA
GATCAAATGATTGCAGAA-3ʹ) were injected into the
lateral ventricle of E12.5 mouse brains, which were given an
electrical stimulation (34 V with 950mA). Four days later, mice
were killed and embryonic brains were ﬁxed in 4%
paraformaldehyde, dehydrated in 30% sucrose and embedded in
O.C.T. (Tissue-Tek, Staufen, Germany ) on dry ice. The brains
were frozen-sectioned into 12 μm slices with Leica CS3050S.
After DNA staining using Hoechst and marker proteins (TBR2-
ab23345 from abcam (Cambridge, UK), PAX6-PRB-278P-100,
and TUJ1-D13AF00117 from Covance) confocal images were
achieved through Leica TCS SP5 confocal microscope (Biber-
ach, Germany) and analyzed using ImageJ (NIH, Bethesda,
MD, USA).
Cell viability analysis
NMuMG cells were transfected with shIft74 green
ﬂuorescent protein using lipofectamine according to
manufacturer’s instructions and trypsinized after 48 h. After
washing the cells two times with cold PBS, 1.5 million cells were
resuspended in 100 μl Annexin binding buffer (0.1M hydro-
xyethyl-piperazineethane-sulfonic acid buffer (HEPES; pH 7.4),
1.4MNaCl and 25 mMCaCl2) supplemented with 5 μl Annexin V
antibody labeled with APC (BD Pharmingen, Heidelberg,
Germany) and incubated 5 min at room temperature in dark.
Then cells were washed twice with 1 ml Annexin binding
buffer, taken up in 400 μl Annexin binding buffer supplemented
with PI and subsequently measured using the BD LSRFortessa
Cell Analyser with BD FACSDiva software (Heidelberg,
Germany).
Migration assay
NMuMG cells were transfected using Lipofectamine 2000
following manufacturer’s protocol with shControl or shIft74
constructs during TGFβ-induced EMT. Cells were again
transfected on the second day and fresh TGFβ was added to
the culture. On the third day, wound was created using a
200 μl pipette tip. Light microscope images were taken at time
0 and 23 h and the derived data was further analyzed
using ImageJ software to quantify closed area after 23 h com-
pared with 0 h.
Microarray expression data
The data from the Affymetrix GeneChip Mouse Gene 1.0 ST
Arrays were imported into R (ver. 2.11.1), normalized with
RMA [74] and annotated with annotation packages from the
Bioconductor repository version 2.6 [75]. A modiﬁed version of
the t-test [76] was used to identify the differentially expressed
genes. The obtained P-values were corrected for by multiple
testing using the Benjamini and Hochberg method. The data is
deposited in GEO database with accession number GSE75256.
ChIP-chip data analysis
The Nimblegen array intensity ﬁles from the GEO data set
GSE30204 were imported into R (ver. 2.11.1), and the log2
enrichments (log2 bound/input ratios) for each individual probe
were calculated using the package Ringo [77]. The Arrays
were loess-normalized using the normalizeWithinArrays
function of the Limma package. For each promoter, we
calculated the average log2 enrichment values using data
obtained from the overlapping probes. Promoters were deﬁned
as 900- bp windows (−700, +200) around the transcription start
sites for genes deﬁned in the Ensembl database (version 58_37k,
http://www.ensembl.org) and the Refseq db (downloaded on
2010-05-28 from http://genome.ucsc.edu). The data is deposited
in GEO database with accession number GSE75256.
Selection of differentially expressed Pax6 targets
To derive a list of bona ﬁde Pax6 targets, we compared the
changes in expression of all Pax6 targets in the Pax6 mutant
compared with those of the WT. We considered only those Pax6
targets that were at least two-fold differentially expressed with
an FDR cutoff of 0.005, which provided a list of genes that were
targeted by Pax6 and differentially expressed in the absence
of Pax6.
RNA-seq analysis
Tissue-speciﬁc data sets were obtained from the Gene
Expression Omnibus with the following GEO accession
numbers: GSE43194 (Heart E11.5), GSM723775 (mouse
embryonic ﬁbroblast E13.5), GSE49581 (Lung E14.5),
GSM1150322 (Pancreas E15.5) and GSE30765 (VZ, SVZ and
CP; E14.5). The reads were aligned to the mouse genome (mm9)
using TopHat [78] with default parameters. The aligned reads
were then provided as an input for the HTSeq_count utility from
the HTSeq package. The raw read count ﬁles obtained from
HTSeq-count were then processed for differential expression
using the DESeq package [79]. The absolute quantiﬁcation of
the transcripts was performed using Cufﬂinks with default
options. The expression data for apical, radial and intermediate
progenitors and neurons were taken from Florio et. al. [44].
The data sets of VZ, SVZ and CP were obtained from
described reference [25] in which authors have used laser
microdissection (LSD) technique to separate out the three main
layer of cortex from E14.5 embryos. In brief, dorsolateral and
medial pallium areas were dissected to obtained progenitor cells
residing in VZ layer. This layer mainly contains apical
progenitor cells. Basal and intermediate progenitors reside in the
SVZ-IZ regions and laser cuts were consistently performed at
the border line of VZ and CP, which resulted in exclusion
Uncovering Pax6-dependent gene-expression program
18
Cell Discovery | www.nature.com/celldisc
of subplate neurons. The CP layer neurons comprise of all
differentiated neuronal subtypes present in adjacent layers, for
example, Cajal–Retzius layer, VIb layer neurons.
The RNA-seq data for in vivo cortical neurogenesis contained
well-deﬁned populations of apical, basal and intermediate
progenitors [44]. Authors in this study used ﬂuorescence-activated
cell sorting to isolate different cell populations from mouse neo-
cortex. Apical radial glial were isolated based on cells that were
positive for Dil, Prom1 and negative for Tubb3 while basal radial
glial were Dil+, Prom− and Tubb3− . Intermediate progenitors
(bIPs) were required to be negative for all three markers and
neurons were isolated from Dil+, Tubb3+ but Prom− popula-
tions. These pure populations of progenitors and neurons were
important for our analysis to analyze expression dynamics of Pax6/
Sox2 target genes in NSCs in later stages of neurogenesis.
ChIP-Seq analysis
The ChIP-Seq data sets for Sox2 were downloaded from GEO
(GSE33059). In this study Sox2 ChIP-seq was performed on NPs
derived from mouse ES cells. The reads were mapped to the
mouse genome (build mm9) using Bowtie (version 0.12.9) [80]
with default parameters. The mapped ﬁles were processed using
MACS (version 2.0.10.2013071) [81] for peak identiﬁcation using
default parameters. Peaks falling at promoters were used to deﬁne
Sox2 target promoters. H3K4me2 and H3K27me3 ChIP-Seq
data was taken fromGSE25533. The genes bound by Ascl1 in the
differentiating NPs were obtained fromRaposo et al. [50]. Brieﬂy,
in this study authors performed ChIP-Seq for Ascl1 after 18 h of
ectopic expression of Ascl1 in NSCs. Pax6 ChIP-Seq peaks were
obtained from a recent study [24]. We assigned each peak to the
nearest gene and then shortlisted only those peaks that were found
to be within ± 1 kb around the transcription start site. These genes
were then compared with our Pax6 targets.
Enrichment analysis
GO cluster and phenotype enrichment analysis was
performed using the ToppGene package [82, 83]. Only the top
20 enriched terms from the GO analysis were plotted. Pathway
enrichment was performed using Genomatix.
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